Missing Data Issues in Regulatory Clinical Trials Lisa M. LaVange, PhD Office of Biostatistics OTS CDER US FDA - Dermatologic and Ophthalmic Drugs Advisory Committee - Document - PDFSEARCH.IO

First Page	Meta Content
	Missing Data Issues in Regulatory Clinical Trials Lisa M. LaVange, PhD Office of Biostatistics OTS/CDER/US FDA Add to Reading List Document Date: 2015-02-24 20:15:37 Open Document File Size: 1,39 MB Share Result on Facebook Company E9(R1) Working Group / / IndustryTerm therapeutic biologic products / / Organization office of Biostatistics / FDA / office of Biostatistics OTS/CDER/US FDA JPMA Symposium / Center for Drug Evaluation and Research / Center for Medical Products and Tobacco / office of Biostatistics Center for Drug Evaluation and Research / Nuclear Regulatory Commission / Center for Devices and Radiological Health / office of Translational Sciences / office of Computational Science / Center for Biologics Evaluation and Research / office of Study Integrity and Surveillance / office of Biostatistics US Food and Drug Administration / Center for Tobacco Products / office of Clinical Pharmacology / / Person Aloka Chakravarty / Daphne Lin / Steve Wilson / Thomas Permutt / James Hung / / Position representative / / Technology drug development / / SocialTag Clinical research Center for Drug Evaluation and Research Bioequivalence Center for Biologics Evaluation and Research Abbreviated New Drug Application Drug development Biologic Biostatistics Dermatologic and Ophthalmic Drugs Advisory Committee Food and Drug Administration

Missing Data Issues in Regulatory Clinical Trials Lisa M. LaVange, PhD Office of Biostatistics OTS/CDER/US FDAAdd to Reading List